ReWalk Robotics Exoskeleton System Donated to Paralyzed British Police Officer by the Gerald Ronson Family Foundation

Retired West Midlands Police Officer Uses ReWalk System to Participate in the 1^st Annual Parallel UK Race

LONDON and YOKNEAM, Israel, Sept. 13, 2016 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk"), the leading global exoskeleton developer and manufacturer, today announced the donation of a ReWalk Personal 6.0 System to Nicki Donnelly, a retired West Midlands Police Officer in the United Kingdom who sustained a spinal cord injury (SCI) while on duty in 2009.  The donation was made by the Gerald Ronson Family Foundation, a charity which aims to help the underprivileged and the community.  More than five years since the accident that left her paralyzed, Ms. Donnelly can now stand and walk again using her ReWalk system.

Logo - http://photos.prnewswire.com/prnh/20150713/235995LOGO

Nicki Donnelly served as a West Midlands Police Officer for nearly ten years.  While on duty in 2009, she was involved in a road traffic collision where she sustained a host of injuries that ultimately left her paralyzed from the chest down.  Donnelly was introduced to ReWalk's technology in 2016, and received her Personal System in April.

On September 4^th, Donnelly showcased her ReWalk system and walking skills at the inaugural Parallel UK races, where she participated in the 1K race wearing her exoskeleton.  "When I was paralyzed, I put a lot of hopes and plans on the shelf," said Donnelly.  "Now that I can stand on my own and walk, I am recommitted to my bucket list.  This race is the first of many I hope to compete in here in the UK and around the world to help advocate for the spinal cord injured community."

"Philanthropic organizations in the United Kingdom have set the standard in providing donations of critical medical technology for its citizens," said Larry Jasinski, CEO of ReWalk Robotics.  "We are thrilled to work with the Gerald Ronson Family Foundation and CST to support Nicki and other spinal cord injured individuals who otherwise may not have access to exoskeleton technology.  On behalf of ReWalk, we also want to congratulate Nicki on her first road race using the ReWalk.  It is always a proud day to see ReWalkers redefining what is possible for the SCI community."

The donation came from the Gerald Ronson Family Foundation's desire to help a wounded police officer who was qualified to use the ReWalk Personal System. The Foundation is a charity based in the United Kingdom.  Gerald Ronson, the Chairman of the Foundation, is also the Chairman of the Community Security Trust (CST), a British Charity set up to protect the Jewish community in Britain from antisemitism and related threats. CST works closely with Police forces nationwide, including the West Midlands Police force. Gerald Ronson is a strong supporter of Policing causes, and is a patron of the The Police Arboretum Memorial Trust.

ReWalk facilitated the connection between the Foundation, CST, and Ms. Donnelly, helping to deliver her customized exoskeleton system upon completion of the required training for home and community use.

"Words cannot express my gratitude towards the Gerald Ronson Family Foundation and CST for their support for me and all law enforcement officers.  I never imagined I would be able to walk again, and with their generous donation, I now am able to utilize ReWalk's life changing technology every day," said Nicki Donnelly.  "Without ReWalk I would not be able to stand tall; it feels as if my freedom of choice has been returned."

Gerald Ronson, Chairman of the Gerald Ronson Family Foundation and CST said, "Our mission at the Gerald Ronson Family Foundation is to help the underprivileged and those in need. It is an honor to provide this donation to Ms. Donnelly.  We celebrate her with every step she takes in her ReWalk system."

David S Delew, Chief Executive of CST said, "We are delighted to be able to support Nicki, who was so badly injured in the line of her duty as a Police officer. Through the generosity of the Gerald Ronson Family Foundation, Gerald Ronson and CST are delighted that this donation will help to enable Nicki to walk again. CST works in close partnership with the Police Service across the UK in the protection of the U.K. Jewish community."

ReWalk Robotics Personal 6.0 is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury to stand upright and walk. ReWalk is the first exoskeleton system to receive FDA clearance for use in the home as well as in the rehabilitation setting.  ReWalk received FDA clearance in June 2014, and a CE mark in June 2010.

For more information, please visit: www.rewalk.com

For photos and video of Nicki Donnelly's Parallel UK race: https://flic.kr/s/aHskDoWooP

About the Gerald Ronson Family Foundation
The Gerald Ronson Family Foundation is a British Charitable Foundation set up by businessman, Gerald Ronson and his family to help the underprivileged and those in need. 

About the Community Security Trust
CST is Community Security Trust, a charity that protects British Jews from antisemitism and related threats. CST received charitable status in 1994 and is recognised by the Police and Government as a unique model of best practice. CST has over 80 full and part-time staff based in offices in London, Manchester and Leeds. CST provides security advice and training for Jewish communal organisations, schools and synagogues. CST secures over 600 Jewish communal buildings and approximately 1,000 communal events every year. CST works across the Jewish community, across the political spectrum and throughout the whole of the UK. CST works closely with Police at local, regional and national levels to help protect Jewish communities. This includes joint patrols in Jewish areas, training classes and exercises, exchange of antisemitic incident data and numerous advisory roles. CST also works with Members of Parliament from all the main political parties and regularly meets government ministers and opposition spokespeople to discuss antisemitism, racism, extremism and terrorism.

About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit http://www.rewalk.com.

ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.

Forward-Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, and Section 21E of the U.S. Securities Exchange Act of 1934. Such forward-looking statements may include projections regarding ReWalk's future performance and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek" and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of ReWalk's control. Important factors that could cause ReWalk's actual results to differ materially from those indicated in the forward-looking statements include, among others: ReWalk's expectations regarding future growth, including its ability to increase sales in its existing geographic markets and to expand to new markets; ReWalk's ability to maintain and grow its reputation and to achieve and maintain market acceptance of its products; ReWalk's ability to achieve reimbursement from third-party payors for its products; ReWalk's expectations as to its clinical research program and clinical results; ReWalk's expectations as to the results of, and the Food and Drug Administration's potential regulatory actions with respect to, ReWalk's mandatory post-market 522 surveillance study; ReWalk's ability to repay its secured indebtedness; ReWalk's ability to improve its products and develop new products; ReWalk's ability to maintain adequate protection of its intellectual property and to avoid violation of the intellectual property rights of others; ReWalk's ability to gain and maintain regulatory approvals; ReWalk's ability to secure capital from its at-the-market equity distribution program based on the price range of its ordinary shares and conditions in the financial markets; ReWalk's ability to maintain relationships with existing customers and develop relationships with new customers; and other factors discussed under the heading "Risk Factors" in ReWalk's Annual Report on Form 10-K for the year ended  December 31, 2015 filed with the U.S. Securities and Exchange Commission and other documents subsequently filed with or furnished to the U.S. Securities and Exchange Commission. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause ReWalk's actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for ReWalk to predict all of them. Except as required by law, ReWalk undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.